• Communications

    Posted in category News by Communications on 02/12/2013

    ABPI and BIVDA event: Generating a NICE assessment for stratified medicines

ABPI and BIVDA are holding the third biopharma-diagnostics networking event 'Generating a NICE assessment for stratified medicines'.


​The event will open with scene-setting perspectives on Health Technology Assessment for personalised medicines from our confirmed speakers:

• Adrian Newland, Chair, NICE Diagnostics Advisory Committee
• Greg Rossi, Vice-President, Payer & Real World Evidence, AstraZeneca
• Berwyn Clarke, Chairman, NALIA Systems Ltd

These will be followed by a panel session, when the speakers will take questions from the audience. Discussion will continue over networking and drinks.

When? Monday 20 January 2014, 4.30-7.30pm
Where? Central London venue to be confirmed

To reserve your place, please email Ivan Dennie, ABPI Events Manager, idennie@abpi.org.uk

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.